EWL:ETR
Edwards Lifesciences
€ 73,66
0,00%
(0,00) 1D
8 okt, 17:35:54 GMT+2 · EUR
search
Alle symbolen
| Symbool | Prijs | Wijziging | Wijzigingspercentage |
|---|
insights_autoBelangrijkste inzichten voor EWL genereren…
Beursw.
48,56 mld.
Gem. vol.
61,00
Volume
0,00
52 wk hoog
€ 84,00
52 wk laag
€ 62,00
Aantal medewerkers
16K
Beursw.
48,56 mld.
Gem. vol.
61,00
Volume
0,00
52 wk hoog
€ 84,00
52 wk laag
€ 62,00
Aantal medewerkers
16K
Nieuwsartikelen
Van webbronnen en nieuwspartners
Investing.com
·
1 uur geleden
Edwards Lifesciences CVP Daniel Lippis sells $53k in stock
Investing.com Nigeria
·
2 uur geleden
Form 4 Edwards Lifesciences Corp For: 9 October By Investing.com
MarketBeat
·
7 uur geleden
Edwards Lifesciences (NYSE:EW) VP Daniel Lippis Sells 619 Shares of Stock
Investing.com
·
15 uur geleden
UBS reiterates Edwards Lifesciences stock rating on endpoint expectations
Profiel
Edwards Lifesciences Corporation is an American medical technology company headquartered in Irvine, California, specializing in tissue heart valves and transcatheter technologies for the treatment of structural heart disease. The company has manufacturing facilities at the Irvine headquarters, as well as in Draper, Utah; Costa Rica; Singapore; and Limerick, Ireland. The company is also constructing a manufacturing plant in Moncada, near Valencia, Spain, with a €150 million investment. Production is scheduled to begin in 2027. Wikipedia
Over Edwards Lifesciences
CEO-
Medewerkers16K
Opgericht1958
HoofdkantoorIrvine, Californië, Verenigde Staten
Sector-
Websiteedwards.com